Alessandro Villa

Dr. Alessandro Villa

Department of Health Sciences, University of Milan, Milan, Italy
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Cell Reports
Verified
Journal Article
Open access
AVAlessandro Villa
Alessandro Villa
PGPaolo Gelosa
Paolo Gelosa
LCLaura Castiglioni
Laura Castiglioni
MCMauro Cimino
Mauro Cimino
NRNicoletta Rizzi
Nicoletta Rizzi
AMAdriana Maggi
Adriana Maggi
Sex has a role in the incidence and outcome of neurological illnesses, also influencing the response to treatments. Neuroinflammation is involved in the onset and progression of several neurological diseases, and the fact that estrogens have anti-inflammatory activity suggests that these hormones may be a determinant in the sex-dependent manifestation of brain pathologies. We describe significant differences in the transcriptome of adult male and female microglia, possibly originating from perinatal exposure to sex steroids. Microglia isolated from adult brains maintain the sex-specific features when put in culture or transplanted in the brain of the opposite sex. Female microglia are neuroprotective because they restrict the damage caused by acute focal cerebral ischemia. This study therefore provides insight into a distinct perspective on the mechanisms underscoring a sexual bias in the susceptibility to brain diseases.

1 September 2004 in Cardiovascular Drug Reviews
Verified
Journal Article
Open access
PDF file
SBSilvia Bradamante
Silvia Bradamante
LBLivia Barenghi
Livia Barenghi
AVAlessandro Villa
Alessandro Villa
Resveratrol (3,4′,5‐trihydroxy‐trans‐stilbene), a phytoalexin found in grape skins, peanuts, and red wine, has been reported to have a wide range of biological and pharmacological properties. It has been speculated that at low doses (such as consumed in the common diet) resveratrol may have cardioprotective activity. In this article we describe recent in vitro and in vivo studies in animal models. The results of these studies suggest that resveratrol modulates vascular cell function, inhibits LDL oxidation, suppresses platelet aggregation and reduces myocardial damage during ischemia‐reperfusion. Although the reported biological data indicate that resveratrol is a highly promising cardiovascular protective agent, more studies are needed to establish its bioavailability and in vivo cardioprotective effects, particularly in humans.

19 May 2016 in Endocrine Reviews
Verified
Journal Article
Open access
PDF file
AVAlessandro Villa
Alessandro Villa
EVElisabetta Vegeto
Elisabetta Vegeto
Angelo PolettiAngelo Poletti
Angelo Poletti
AMAdriana Maggi
Adriana Maggi
Inflammatory activation of microglia is a hallmark of several disorders of the central nervous system. In addition to protecting the brain against inflammatory insults, microglia are neuroprotective and play a significant role in maintaining neuronal connectivity, but the prolongation of an inflammatory status may limit the beneficial functions of these immune cells. The finding that estrogen receptors are present in monocyte-derived cells and that estrogens prevent and control the inflammatory response raise the question of the role that this sex steroid plays in the manifestation and progression of pathologies that have a clear sex difference in prevalence, such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The present review aims to provide a critical review of the current literature on the actions of estrogen in microglia and on the involvement of estrogen receptors in the manifestation of selected neurological disorders. This current understanding highlights a research area that should be expanded to identify appropriate replacement therapies to slow the progression of such diseases.

1 December 2014 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
AVAlessandro Villa
Alessandro Villa
CCChristopher Connell
Christopher Connell
SASilvio Abati
Silvio Abati
Diagnosis and management of xerostomia and hyposalivation Alessandro Villa,1,2 Christopher L Connell,3 Silvio Abati4 1Division of Oral Medicine and Dentistry, Brigham and Women’s Hospital, Boston, MA, USA; 2Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA; 3Department of General Dentistry, Boston University Henry M Goldman School of Dental Medicine, Boston, MA, USA; 4Dental Clinic, Department of Health Sciences, University of Milan, Milano, Italy Xerostomia, the subjective complaint of dry mouth, and hyposalivation remain a significant burden for many individuals. Diagnosis of xerostomia and salivary gland hypofunction is dependent upon a careful and detailed history and thorough oral examination. There exist many options for treatment and symptom management: salivary stimulants, topical agents, saliva substitutes, and systemic sialogogues. The aim of this review is to investigate the current state of knowledge on management and treatment of patients affected by xerostomia and/or hyposalivation.

19 October 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AVAlessandro Villa
Alessandro Villa
NRNicoletta Rizzi
Nicoletta Rizzi
EVElisabetta Vegeto
Elisabetta Vegeto
PCPaolo Ciana
Paolo Ciana
AMAdriana Maggi
Adriana Maggi
Although 17β-estradiol (E2) anti-inflammatory activity has been well described, very little is known about the effects of this hormone on the resolution phase of the inflammatory process. Here, we identified a previously unreported ERα-mediated effect of E2 on the inflammatory machinery. The study showed that the activation of the intracellular estrogen receptor shortens the LPS-induced pro-inflammatory phase and, by influencing the intrinsic and extrinsic programs, triggers the resolution of inflammation in RAW 264.7 cells. Through the regulation of the SOCS3 and STAT3 signaling pathways, E2 facilitates the progression of the inflammatory process toward the IL10-dependent “acquired deactivation” phenotype, which is responsible for tissue remodeling and the restoration of homeostatic conditions. The present study may provide an explanation for increased susceptibility to chronic inflammatory diseases in women after menopause and it suggests novel anti-inflammatory treatments for such disorders.

1 January 2020 in Journal of Otolaryngology - Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
NRNaman Rao
Naman Rao
AVAlessandro Villa
Alessandro Villa
CMChandramani B. More
Chandramani B. More
RJRuwan Jayasinghe
Ruwan Jayasinghe
AKAlexander R. ross Kerr
Alexander R. ross Kerr
NJNewell Johnson
Newell Johnson
Oral Submucous fibrosis (OSMF) has traditionally been described as “a chronic, insidious, scarring disease of the oral cavity, often with involvement of the pharynx and the upper esophagus”. Millions of individuals are affected, especially in South and South East Asian countries. The main risk factor is areca nut chewing. Due to its high morbidity and high malignant transformation rate, constant efforts have been made to develop effective management. Despite this, there have been no significant improvements in prognosis for decades. This expert opinion paper updates the literature and provides a critique of diagnostic and therapeutic pitfalls common in developing countries and of deficiencies in management. An inter-professional model is proposed to avoid these pitfalls and to reduce these deficiencies.